ArticleCancers2023

Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.

Kazunari Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.